Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (11)

2022

  1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

2020

  1. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  2. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Mucosal RNA and protein expression as the next frontier in IBS: Abnormal function despite morphologically intact small intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 316, Núm. 6, pp. G701-G719

2018

  1. Epithelial immunity: Priming defensive responses in the intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

2016

  1. Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells

    Vascular Pharmacology, Vol. 80, pp. 20-34

2015

  1. Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome

    Biomarkers in Medicine, Vol. 9, Núm. 3, pp. 209-216

  2. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

    Gut, Vol. 64, Núm. 9, pp. 1379-1388

  3. Key structural and functional differences between early and advanced glycation products

    Journal of Molecular Endocrinology, Vol. 56, Núm. 1, pp. 23-37